Human polo-like kinase 1 (Plk1) is a serine/threonine-protein kinase 13(STPK13), which is overexpressed in human tumor cells. Plk1 consists of N-terminal kinase domain and C-terminal two polo-box domains. Polo-box domain (PBD) interacts with phosphoserine/phosphothreonine (pS/pT)-containing motif and is critical for tumorigenesis. Based on the crystal structure of hPlk1-PBD and PLHSpT, we designed a series of PLHSpT-derived peptide analogues to improve the binding affinity. To examine the interaction mode between hPlk1-PBD and peptide inhibitors in detail, hPlk-PBD protein was purified and crystallized with peptide analogues. Here, we report the crystal structures of hPlk1-PBD in complex with several peptide inhibitors. Acinetobacter baumannii is a multi-drug resistant Gram-negative pathogen that causes hospital-acquired infection of immunocompromised patients. Peptidoglycan-associated lipoprotein (Pal) of Gram-negative bacteria is one component of the Tol-Pal system, which plays an important role in the integrity of the outer membrane and it is found in the outer membrane vesicle used to deliver virulence effectors into host cells. A. baumannii Pal (AbPal) is composed of an N-terminal motif that is required for delivery and anchoring to the outer membrane and a C-terminal OmpA-like domain. OmpA-like domains interact noncovalently with peptidoglycan via a unique bacterial amino acid, meso-diaminopimelic acid (meso-DAP).
Incorporation of a D-amino acid moiety in the peptidoglycan structure has been suspected to be a method which bacteria can evade the host immune system. Specific binding to D-amino acid by this domain is of particular interest in terms of pathogenicity{Walsh, 1989 #31}{Walsh, 1989 #31}. However, the enantiomeric specificity of OmpA-like domains for the interaction with peptidoglycan has not been studied.
Here, we report molecular basis for the interaction with meso-DAP of peptidoglycan by OmpA-like domain of AbPal using X-ray crystallography, NMR spectroscopy, isothermal titration calorimetry (ITC), and site-directed mutagenesis. We performed the NMR backbone assignment of AbPal and firstly solved the crystal structure of AbPal in complex with meso-DAP or LL-DAP to evaluate a key determinant region for the stereospecific interaction with peptidoglycan. Our findings provide a foundation for the development of antibacterial agents that disrupt stability of cell wall of Gram-negative pathogen.
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